UK breakfast cereal maker Weetabix will be one of the first companies this year to test the market for leveraged recapitalizations. The deal, expected to come to market in the next few weeks, will be lead arranged by JPMorgan. It takes out the £450 million ($803 million) leveraged loan backing the £642 million buyout of Weetabix in 2004 by private equity firm Hicks Muse Tate and Furst.
The original loan was one of the first to include flexing down of margins after the deal closed – now a common component of European leveraged loans.
Thanks for your interest in Euromoney!
To unlock this article:
